Loading insider details...
Beta
Latest Form 4 (Aug 26, 2026): Grant/Award of 25 GOSS shares, $25.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 25 | $25.0K |
| May 12, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 24,000 | $154.8K |
| Mar 20, 2026 | Gossamer Bio, Inc. (GOSS) | Disposition to Issuer | 693,750 | n/a |
| Jan 7, 2026 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 2,695 | n/a |
| Jan 5, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,750 | n/a |
| Oct 2, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 181,250 | n/a |
| Mar 6, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 638,000 | n/a |
| Jan 6, 2025 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 5,130 | n/a |
| Jun 21, 2024 | Gossamer Bio, Inc. (GOSS) | Purchase | 100,000 | $59.1K |
| Mar 28, 2024 | Gossamer Bio, Inc. (GOSS) | Sale | 6,430 | $7.4K |